Impact of Multi-Drug-Resistant Pneumonia on Outcomes of Critically Ill Trauma Patients.

Background: Rates of infections with multi-drug-resistant organisms (MDROs) are increasing among critically ill patients. Among non-surgical patients, MDROs increase directly the risk of adverse secondary events including death. However, similar effects do not appear to occur among surgical patients. Specifically, among critically injured trauma patients, it is unknown whether degree of injury versus the presence of an MDRO increases the risk of death. Methods: This is a retrospective chart review of admitted adult trauma patients. Data included demographics, medical comorbidities, injury severity score, infections, occurrence of pneumonia including microbiology sensitivity profile, hospital course, and outcomes. Results: Patients requiring adminission to the intensive care unit (ICU) were more severely injured with greater degree of thoracic and head trauma and had a greater burden of pre-trauma medical comorbidities. Among those admitted to the ICU, 93 patients developed pneumonia. Patients who developed pneumonia were younger and more severely injured, with higher rates of thoracic and head injuries and higher rates of smoking. Development of pneumonia was associated with worse outcomes. However, among patients with pneumonia, comparing MDRO to pan-sensitive (PanSens) infections, PanSens infection occurred earlier and were more likely associated with pre-trauma smoking status. There was no difference in injury patterns, medical comorbidities, or outcomes. Conclusion: The development of pneumonia among trauma patients reflects degree of injury and underlying medical status. However, development of MDRO versus PanSens pneumonia did not affect trauma-related outcomes further. This information will guide family discussions and critical care decisions better among vulnerable trauma patients.

[1]  D. Heffernan,et al.  Practice Makes Perfect: The Evolution of Blunt Chest Trauma. , 2019, Rhode Island medical journal.

[2]  T. Tolker-Nielsen,et al.  Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents—How P. aeruginosa Can Escape Antibiotics , 2019, Front. Microbiol..

[3]  Y. Chawla,et al.  Presence of Multidrug-resistant Infections at Admission Predict 28-day mortality in Acute Decompensation of Cirrhosis. , 2019, Journal of gastroenterology and hepatology.

[4]  P. Barbadoro,et al.  Epidemiology and Risk Factors for Isolation of Multi-Drug-Resistant Organisms in Patients with Complicated Intra-Abdominal Infections. , 2018, Surgical infections.

[5]  M. Reed,et al.  Antibiotic resistance profiles of deep surgical site infections in hip hemiarthroplasty; comparing low dose single antibiotic versus high dose dual antibiotic impregnated cement , 2018, Journal of bone and joint infection.

[6]  Gerard D. Wright,et al.  Antibiotic resistance: it’s bad, but why isn’t it worse? , 2017, BMC Biology.

[7]  C. Aibar-Remon,et al.  Impact on Morbidity, Mortality, and Length of Stay of Hospital-Acquired Infections by Resistant Microorganisms , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  A. Anzueto,et al.  Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics? , 2017, International journal of molecular sciences.

[9]  Y. Carmeli,et al.  The negative impact of antibiotic resistance. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  M. Kollef,et al.  How to stratify patients at risk for resistant bugs in skin and soft tissue infections? , 2016, Current opinion in infectious diseases.

[11]  D. Fry.  Article Commentary: The Continued Challenge of Staphylococcus aureus in the Surgical Patient , 2013, The American surgeon.

[12]  L. Kaplan,et al.  Antibiotic heterogeneity optimizes antimicrobial prescription and enables resistant pathogen control in the intensive care unit. , 2012, Surgical infections.

[13]  J. Machan,et al.  Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern , 2012, Critical Care.

[14]  R. Sawyer,et al.  Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view. , 2011, Journal of the American College of Surgeons.

[15]  C. Hogea,et al.  Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion. , 2011, Microbial drug resistance.

[16]  S. Norwood,et al.  Ventilator-associated pneumonia is more common and of less consequence in trauma patients compared with other critically ill patients. , 2010, The Journal of trauma.

[17]  R. Daum,et al.  Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic , 2010, Clinical Microbiology Reviews.

[18]  H. Boucher,et al.  Epidemiology of methicillin-resistant Staphylococcus aureus. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Y. Carmeli,et al.  Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. , 2007, The Journal of antimicrobial chemotherapy.

[20]  H. Evans,et al.  Cost of Gram‐negative resistance* , 2007, Critical care medicine.

[21]  Peter Rhee,et al.  Trauma deaths in a mature urban trauma system: is "trimodal" distribution a valid concept? , 2005, Journal of the American College of Surgeons.

[22]  T. Fabian,et al.  Is ventilator-associated pneumonia in trauma patients an epiphenomenon or a cause of death? , 2004, Surgical infections.

[23]  S. Cosgrove,et al.  The impact of antimicrobial resistance on health and economic outcomes. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  T. Crabtree,et al.  Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients , 2003, Critical care medicine.

[25]  S. Cosgrove,et al.  Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  W. Bilker,et al.  Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.